Citation 86327

DUAN,H: TAKAISHI,Y: MOMOTA,H: OHMOTO,Y: TAKI,T: JIA,Y: LI,D:. (2001). IMMUNOSUPPRESSIVE SESQUITERPENE ALKALOIDS FROM TRIPTERGIUM WILFORDII.. 64(5)

Citation Details

Title	IMMUNOSUPPRESSIVE SESQUITERPENE ALKALOIDS FROM TRIPTERGIUM WILFORDII.
Authors	DUAN,H: TAKAISHI,Y: MOMOTA,H: OHMOTO,Y: TAKI,T: JIA,Y: LI,D:
Year	2001
Volume	64
Issue	5

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Tripterygium wilfordii (CELASTRACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORNINE A	None
2	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE A	INACTIVE
3	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE A	INACTIVE
4	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE A	INACTIVE
5	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE A	WEAK ACTIVITY
6	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE A	ACTIVE
7	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE A	INACTIVE
8	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORNINE B	None
9	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE B	INACTIVE
10	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE B	INACTIVE
11	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE B	INACTIVE
12	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE B	WEAK ACTIVITY
13	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE B	ACTIVE
14	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE B	INACTIVE
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORNINE C	None
16	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE C	INACTIVE
17	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE C	INACTIVE
18	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE C	INACTIVE
19	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE C	ACTIVE
20	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE C	ACTIVE
21	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE C	ACTIVE
22	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORNINE D	None
23	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE D	INACTIVE
24	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE D	INACTIVE
25	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE D	INACTIVE
26	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE D	INACTIVE
27	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE D	INACTIVE
28	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE D	INACTIVE
29	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORNINE E	None
30	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE E	INACTIVE
31	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE E	INACTIVE
32	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE E	INACTIVE
33	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE E	INACTIVE
34	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE E	INACTIVE
35	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE E	INACTIVE
36	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORDININE I	None
37	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE I	INACTIVE
38	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE I	INACTIVE
39	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE I	INACTIVE
40	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE I	INACTIVE
41	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE I	INACTIVE
42	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE I	INACTIVE
43	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORDININE J	None
44	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE J	INACTIVE
45	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE J	INACTIVE
46	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE J	INACTIVE
47	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE J	INACTIVE
48	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE J	INACTIVE
49	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORDININE J	INACTIVE
50	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORNINE F	None
51	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE F	INACTIVE
52	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE F	INACTIVE
53	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE F	INACTIVE
54	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE F	INACTIVE
55	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE F	INACTIVE
56	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORNINE F	None
57	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	WILFORNINE G	None
58	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE G	INACTIVE
59	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE G	INACTIVE
60	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE G	INACTIVE
61	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE G	INACTIVE
62	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE G	INACTIVE
63	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFORNINE G	INACTIVE
64	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EBENIFOLINE E-II	None
65	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EBENIFOLINE E-II	ACTIVE
66	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EBENIFOLINE E-II	ACTIVE
67	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EBENIFOLINE E-II	ACTIVE
68	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EBENIFOLINE E-II	ACTIVE
69	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EBENIFOLINE E-II	ACTIVE
70	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EBENIFOLINE E-II	ACTIVE
71	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HYPONINE D	None
72	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPONINE D	INACTIVE
73	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPONINE D	INACTIVE
74	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPONINE D	INACTIVE
75	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPONINE D	ACTIVE
76	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPONINE D	ACTIVE
77	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYPONINE D	INACTIVE
78	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MAYTEINE	None
79	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAYTEINE	INACTIVE
80	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAYTEINE	INACTIVE
81	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAYTEINE	INACTIVE
82	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAYTEINE	ACTIVE
83	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAYTEINE	INACTIVE
84	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAYTEINE	WEAK ACTIVITY
85	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EUONYMINE	None
86	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUONYMINE	ACTIVE
87	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUONYMINE	ACTIVE
88	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUONYMINE	WEAK ACTIVITY
89	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUONYMINE	ACTIVE
90	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUONYMINE	INACTIVE
91	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUONYMINE	WEAK ACTIVITY
92	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CONGORININE E-1	None
93	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CONGORININE E-1	ACTIVE
94	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CONGORININE E-1	ACTIVE
95	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CONGORININE E-1	ACTIVE
96	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CONGORININE E-1	ACTIVE
97	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CONGORININE E-1	ACTIVE
98	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CONGORININE E-1	ACTIVE
99	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TRIPTONINE A#	None
100	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTONINE A#	ACTIVE
101	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTONINE A#	ACTIVE
102	INTERLEUKIN 8 INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTONINE A#	ACTIVE
103	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTONINE A#	ACTIVE
104	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTONINE A#	INACTIVE
105	INTERFERON-GAMMA SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTONINE A#	WEAK ACTIVITY

Citation 86327

Citation Details

Summary

Organisms and Their Experiments (1)

Tripterygium wilfordii (CELASTRACEAE)

Show SPARQL Queries (1)

Query 1